In 2012, Mr Joshua Shaw the original inventor met Debbie and identified her as his successor being a trusted, loyal friend and also an independent scientist. They worked together daily from 2013 to rebuild his business following his earlier retirement and continued servicing the many Elanra customers. Unfortunately, due to a stroke around 2014 which resulted in a drawn out divorce through 2015 Mr Shaw had to find alternate accommodation, so the rebuild of Elanra took place from his bedside in rehabilitation and aged care homes.
By January 2020 an opportunity in Wuhan alongside the research results Debbie had from her Decentralised Hybrid Clinical Research Unit, she improved Mr Shaw’s invention whilst keeping its key foundational integrity out of respect to him. The company was forbidden to advertise their results from Wuhan and so Debbie focussed on independent research and science where there was no boundary to intellectual creativity, in an effort to assist the human body recover itself from any illness. One of the key solutions she implemented came out of Oceanography, which she adapted to clinical practice in human health!
Debbie owns the world’s first patent for developing a ‘systemic selective adaptogen’ by producing an abundance of the Master Metaboliser H2 (Molecular Hydrogen) inside the human body and ensuring it is regulated by that individual’s own body to suit the persons own physiological needs. All as one sleeps with no effort. That’s like the key for every single cell to assist the body heal itself. Importantly, because it’s a physics solution it does not interfere with pharmaceuticals, herbal remedies, traditional Chinese medicines or vaccines, it has no side effects.
Studying 39 different fields of medicine and science in narrow focussed subject areas searching for a new solution is not possible through Academia. Although not a deep expert in any one field, having a vision on the end goal created research knowledge that opened new horizons. In 2023, Debbie was accepted by a University in California for her PhD where she will debate a thesis on: “The Nexus between Eschatology, Neuroquantology and Epigenetics.” In other words, she is studying our new global environment and its impacts on human health especially our mind through the eyes of the unseen world in quantum physics and then relating that to what the Biblical prophecies tell us about the times we are living in and what we can do about it.
“It’s an honour to take forward and improve the foundational work that Mr Shaw spent his whole life developing, and spent many years protecting and vehemently fighting for. Today, we are assisting patients of all ages, with any condition, from their bedside, and gently over time, still with no side effects and consistent results.
不幸的是，现代临床试验仍然是这种设备的真正挑战，因为它们理所当然地要求严格控制谁可以被纳入研究，以限制潜在的变量并专注于一种疾病。然而，我们庞大的患者数据库表明，患者的健康变量（疾病）越多，他们的结果和体验就越好，随着时间的推移。因此，虽然测试一种疾病将满足临床试验的要求，但它不能解释我们的低风险设备在所有患者中的潜在好处，特别是那些由细菌、病毒和其他病原体引起的疾病，包括我们的老年人群体。
Dr Mark Edwards said, “Though multiple claims for one medical device can provoke scepticism, many non-specific effects are common when the target system(s) of treatments, govern the activities and functions of many different aspects of the organism such as the respiratory, immune, hormonal and central nervous systems.” Results from this medical device have been repeatable and consistent. It’s success of assisting treat and preventing pathogens of any mutation and not interfering with existing medicines and vaccines, appear to be linked to is mechanisms of being a ‘physics solution’ and not a ‘chemical solution’. This science belongs to humanity, not just Australians. – Ms Debbie Sommerville (2021).
Mr Joshua Shaw (1938–2019) was the inventor of the original science and technology of the Elanra medical devices. He first began his research into ‘therapeutic small air ions’ with a negative charge around 1967, eventually naming his medical devices ‘Elanra’. He spent his last 7 years with his protege Debbie Sommerville. In 2009, an independent professional study across 973 patients resulted in 95% reporting “less colds and flu” and 93% “actively recommending these medical devices to their family and friends.”
20世纪60年代，Elanra设备的创新设计推动了气体电离和物理学领域的发展，使其超越了杀菌和空气净化的应用，而走向了医疗治疗的目的。因此，在20世纪70年代，澳大利亚卫生部（现称治疗用品管理局（TGA））认为，该设备的官方描述是"治疗性空气电离器"，这使得澳大利亚卫生部（TGA）成为世界上第一个承认这些对人类健康有益的设备，是一个新的国际医学分类。然而，当时由于工具不具备，无法对其科学性进行测试。直到很久以后（2018年），随着新的改进，这项技术才被国际顶尖的学术教授认可，成为一种低风险的"冷空气等离子体（CAP）医学与量子物理相结合，产生治疗性健康空气物种"。治疗意味着这些独特的空气物种对人体具有生物活性。它们以一种特殊的方式被吸入，通过呼吸系统进入血液，并通过皮肤吸收，对人体健康系统产生积极的治疗和生物效应，所有这些都是在病人睡觉时进行的。
乔舒亚-肖先生在20世纪80年代写道"获奖的Elanra MkII(2003年日内瓦发明家奖)通过在不同频率下复制自然界的小负氧离子来增强健康和保健，就像我们在瀑布旁、海边或雷雨后所体验到的一样。只有使用这种Elanra治疗设备，您才能在家中、办公室或外出时，通过呼吸自然界的小氧离子，获得巨大的健康益处。"
这项科技不仅仅是一台离子机，更是一台空气净化器。它不仅仅是一个空气净化器。它是为你的身体和血液设计的，通常在你的床边，作为副作用，它也会同时净化空气和表面的病原体。多年来，该公司在其私人数据库中逐步认真记录了该医疗设备在各种疾病中的患者所表达的积极效果。截至2021年1月，公司有71个同时进行的临床案例研究试验正在进行中，试验对象是由我们自己的患者领导的一系列疾病。截至2021年，公司数据库被公认为拥有世界上最大的人类使用血浆医学的记录。自1967年以来，没有发生过召回事件，也没有发生过对人类健康的不良事件。
从1967年到2020年，该公司选择不公布其人体成果，也不在任何期刊上发表有关其在100多万患者中的成功经验，依靠有机生长。当时的科学技术是超前的，它的活性机制不被科学界、医学界和政界的兄弟们所接受，因为它不被理解。同时它也不能用科学的方法来衡量，也不能用当时的语言来解释，只能通过它在人体内的积极结果来体验，这还不够。2021年，这种趋势将发生变化，因为一些利益相关者现在欢迎公共卫生方面的成果，接受看不见的东西，特别是当它在人体中显示出长期疗效时。
肖先生的动机。
不幸的是，Joshua Shaw先生于2019年3月5日去世。人们非常怀念和敬佩他为澳大利亚人类健康所做的一切。
一个人在1947年目睹了他的弟弟Simeon在5岁时痛苦地死去后，将自己的生命献给了这项发明。另一个国家的科学家们正在寻求冷战中使用的知识。患有早期骨癌的Simeon在没有得到父母知情同意的情况下，被注射了"放射性钚"作为实验，这样科学就可以了解人体在活着的时候会发生什么。Simeon在接受这种"治疗"9个月后死亡。这种做法在今天是被禁止的。相关国家最终向约书亚和他的家人正式道歉，并在澳大利亚电视台播出。这件事给肖先生留下了深深的伤痕，也促使他成为了这样的人，并为人类创造了技术。
仅限卫生专业人员
为您的患者提供辅助设备，对您推荐的任何处方进行补充。Elanra与任何药物都不冲突。该设备有助于清除途径，以更好地吸收和更有效的结果，因此药物可以发挥预期的作用，而不会受到可能改变疗效的负面内部污染物的阻碍。